Advertisement
Screener

CYTOSORBENTS CORPORATION (CTSO) ROI

CYTOSORBENTS CORPORATION (CTSO) ROI

  • 2026-06-30: ROI -110.45%.
  • 2026-03-31: ROI -61.86%.
  • 2024-03-31: ROI -116.44%.
  • 2023-12-31: ROI -102.54%.

Complete source-backed roi history.

Available history
2015-12-31 to 2026-06-30
Data captured

Historical ROI

DateROI
2026-06-30-110.45%
2026-03-31-61.86%
2024-03-31-116.44%
2023-12-31-102.54%
2023-09-30-98.30%
2020-12-31-9.89%
2020-09-30-11.65%
2020-06-30-43.49%
2020-03-31-48.99%
2019-12-31-104.31%
2019-09-30-95.26%
2019-06-30-78.21%
2019-03-31-76.51%
2018-12-31-64.04%
2018-09-30-49.87%
2018-06-30-44.52%
2018-03-31-40.79%
2017-12-31-41.77%
2017-09-30-52.57%
2017-06-30-57.98%
2017-03-31-346.35%
2016-12-31-191.00%
2016-09-30-165.36%
2015-12-31-96.25%

Annual ROI

DateROI
2023-12-31-102.54%
2020-12-31-9.89%
2019-12-31-104.31%
2018-12-31-64.04%
2017-12-31-41.77%
2016-12-31-188.24%
2015-12-31-96.25%

Similar stocks

Stock NameCountryMarket CapPE Ratio
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92
Mobia Medical, Inc. (MOBI)United States$0.293B
InfuSystem Holdings, Inc (INFU)United States$0.253B22.52
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32
UTAH MEDICAL PRODUCTS INC (UTMD)United States$0.238B20.93
PRO DEX INC (PDEX)United States$0.234B13.64
Embecta Corp. (EMBC)United States$0.319B2.10
Neuronetics, Inc. (STIM)United States$0.216B-3.25